- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00965640
Treatment of Male Pattern Baldness With Botulinum Toxin
August 24, 2009 updated by: The Crown Institute
A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia
This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Pickering, Ontario, Canada, L1V 1B1
- Crown Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male pattern baldness
- Norwood II-VI
Exclusion Criteria:
- Treatment with Botulinum toxins or other hair growth interventions with past year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Hair Growth
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Hair Loss
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brian Freund, MD, Crown Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2002
Primary Completion (Actual)
June 1, 2004
Study Completion (Actual)
June 1, 2004
Study Registration Dates
First Submitted
August 24, 2009
First Submitted That Met QC Criteria
August 24, 2009
First Posted (Estimate)
August 25, 2009
Study Record Updates
Last Update Posted (Estimate)
August 25, 2009
Last Update Submitted That Met QC Criteria
August 24, 2009
Last Verified
August 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Skin Diseases
- Pathological Conditions, Anatomical
- Hypotrichosis
- Hair Diseases
- Alopecia
- Alopecia Areata
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Cholinergic Agents
- Membrane Transport Modulators
- Acetylcholine Release Inhibitors
- Botulinum Toxins
Other Study ID Numbers
- MPB-2002-01
- HPB 081023
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male Pattern Baldness
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Awareable Technologies IncRecruitingMale Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
Clinical Trials on Botulinum Toxin - A injections
-
AllerganTerminatedOveractive BladderSerbia, Turkey, Greece, Egypt, Lebanon, India
-
Walter Reed Army Medical CenterUnknown
-
YangHuiUnknown
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar RhytidesUnited States
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar Rhytides | Frown Lines Between the EyebrowsUnited States
-
University Hospital of Mont-GodinneUnknownStroke | SpasticityBelgium
-
University of Campinas, BrazilConselho Nacional de Desenvolvimento Científico e Tecnológico; Cristália Produtos...CompletedHereditary Spastic ParaplegiaBrazil